ACAS, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.

Quarter-by-quarter ownership
ACAS, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2023$214,007
-8.6%
7,108
-1.8%
0.29%
-14.3%
Q1 2023$234,194
+12.9%
7,239
-0.0%
0.34%
+5.0%
Q4 2022$207,509
-2.1%
7,240
-10.2%
0.32%
+0.9%
Q2 2022$212,000
-31.4%
8,0580.0%0.32%
-24.0%
Q1 2022$309,000
+19.8%
8,0580.0%0.42%
+25.2%
Q4 2021$258,000
+10.7%
8,058
+1.7%
0.33%
+2.5%
Q3 2021$233,000
-18.2%
7,923
-5.4%
0.32%
-19.4%
Q2 2021$285,000
+2.9%
8,376
-1.8%
0.40%
-7.1%
Q1 2021$277,0008,5260.43%
Other shareholders
VANECK VECTORS ETF TR shareholders Q2 2023
NameSharesValueWeighting ↓
Hollow Brook Wealth Management LLC 711,589$25,631,00015.27%
Sloane Robinson LLP 450,000$16,209,00015.04%
New Harbor Financial Group, LLC 1,103,389$39,744,00014.30%
Brown University 541,096$19,490,00014.10%
Grand Central Investment Group 426,777$15,373,00013.75%
New Harbor Financial Group, LLC 1,055,400$38,015,00013.68%
Memorial Sloan Kettering Cancer Center 738,500$26,601,00011.26%
Brevan Howard Capital Management LP 1,420,000$51,148,00010.26%
Nokomis Capital, L.L.C. 603,528$21,739,0009.52%
tru Independence LLC 139,120$5,011,102,0009.10%
View complete list of VANECK VECTORS ETF TR shareholders